Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.
This Week’s Highlights
Herself Health raises $26M in Series A funding to reinvent healthcare for women 65+.
Incontinence care company Attn: Grace adds $2M to invest in growth.
Waverly Diagnostics adds $1.35M to enhance its digital diagnostics platform for childhood ear infections.
Sustainable period care brand &SISTERS acquires Mooncup in a bid to combat single-use plastic.
Big Health acquires Limbix to address the adolescent mental health crisis.
Perrigo receives FDA approval for Opil, its over-the-counter oral contraceptive.
Center for Intimacy Justice and US Senators call on the FTC to investigate Meta’s rejection of women’s sexual health ads.
Google teams up with Cypriot femtech startup Soula to advance pregnancy care.
VICHY Laboratories and Embr Labs partner to bring clinically proven care to women in menopause.
In the Know
Innovation in Maternal Health: Challenges and Opportunities (Femtech Insider)
Frost & Sullivan Unveils the Top Growth Opportunities in Women’s Health in 2030 (Femtech Insider)
Misinformation, misogyny, and money: how community could be the key to unlock FemTech (Maddyness)
Sperm Fever (NY Mag)
A Study Used Sensors to Show That Men and Women Are Treated Differently at Work (HBR)
3 Simple Reasons Why Women Will Be the First Adopters of Neurotechnology (Emilė Radytė / Medium)
How telehealth startups are trying to fill the menopause care vacuum (STAT News)
Dundee scientists create world-first ‘micro placenta’ (Herald Scotland)
FemTech Startups Want To Unlock The Potential Of Menstrual Blood (Forbes)
